SEQUENT SCIENTIFIC LTD.

Company Profile

SEQUENT SCIENTIFIC LTD. had its IPO on under the ticker symbol SEQUENT.

The company operates in the sector and industry. SEQUENT SCIENTIFIC LTD. has a staff strength of 0 employees.

Stock update

Shares of SEQUENT SCIENTIFIC LTD. opened at ₹91.73 at the start of the last trading session i.e. 2023-09-13.

The stocks traded within a range of ₹87.3 - ₹92, and closed at ₹87.61.

This is a -4.46% slip from the previous day's closing price.

A total volume of 76,491 shares were traded at the close of the day’s session.

In the last one week, shares of SEQUENT SCIENTIFIC LTD. have slipped by -4.47%.

SEQUENT SCIENTIFIC LTD.'s Key Ratios

SEQUENT SCIENTIFIC LTD. has a market cap of ₹19.67 billion, indicating a price to book ratio of 3.108 and a price to sales ratio of 1.6276.

In the last 12-months SEQUENT SCIENTIFIC LTD.’s revenue was ₹0 with a gross profit of ₹5.57 billion and an EBITDA of ₹0. The EBITDA ratio measures SEQUENT SCIENTIFIC LTD.'s overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, SEQUENT SCIENTIFIC LTD.’s operating margin was 0% while its return on assets stood at 0% with a return of equity of 94.32%.

In Q4, SEQUENT SCIENTIFIC LTD.’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.

SEQUENT SCIENTIFIC LTD.’s PE and PEG Ratio

Forward PE

33.3333

Trailing PE

25.2076

PEG

Its diluted EPS in the last 12-months stands at ₹0 per share while it has a forward price to earnings multiple of 33.3333 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into SEQUENT SCIENTIFIC LTD.’s profitability.

SEQUENT SCIENTIFIC LTD. stock is trading at a EV to sales ratio of 1.8885 and a EV to EBITDA ratio of 33.2324. Its price to sales ratio in the trailing 12-months stood at 1.6276.

SEQUENT SCIENTIFIC LTD. stock pays annual dividends of ₹0.2 per share, indicating a yield of 0.27% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

₹14.93 billion

Total Liabilities

₹4.99 billion

Operating Cash Flow

₹0

Capital Expenditure

₹0

Dividend Payout Ratio

0%

SEQUENT SCIENTIFIC LTD. ended 2024 with ₹14.93 billion in total assets and ₹0 in total liabilities. Its intangible assets were valued at ₹14.93 billion while shareholder equity stood at ₹7.38 billion.

SEQUENT SCIENTIFIC LTD. ended 2024 with ₹0 in deferred long-term liabilities, ₹4.99 billion in other current liabilities, 498860000.00 in common stock, ₹6.88 billion in retained earnings and ₹2.32 billion in goodwill. Its cash balance stood at ₹408.49 million and cash and short-term investments were ₹417.97 million. The company’s total short-term debt was ₹0 while long-term debt stood at ₹1.52 billion.

SEQUENT SCIENTIFIC LTD.’s total current assets stands at ₹7.71 billion while long-term investments were ₹0 and short-term investments were ₹9.48 million. Its net receivables were ₹3.09 billion compared to accounts payable of ₹2.18 billion and inventory worth ₹3.72 billion.

In 2024, SEQUENT SCIENTIFIC LTD.'s operating cash flow was ₹0 while its capital expenditure stood at ₹0.

Comparatively, SEQUENT SCIENTIFIC LTD. paid ₹0 in dividends in 2024.

Other key metrics

Current Trading Price

₹87.61

52-Week High

₹135.5

52-Week Low

₹61.8

Analyst Target Price

₹

SEQUENT SCIENTIFIC LTD. stock is currently trading at ₹87.61 per share. It touched a 52-week high of ₹135.5 and a 52-week low of ₹135.5. Analysts tracking the stock have a 12-month average target price of ₹.

Its 50-day moving average was ₹91.07 and 200-day moving average was ₹82.13 The short ratio stood at 0 indicating a short percent outstanding of 0%.

Around 0% of the company’s stock are held by insiders while 0% are held by institutions.